Sumatriptan-Naproxen for the treatment of acute migraine


featured image

Sumatriptan-naproxen is for the acute treatment of migraine. Migraine is a headache that is usually characterised by throbbing in one side of the head and other symptoms including sensitivity to light and sound, nausea and vomiting.

Interventions: Sumatriptan-Naproxen
Indications: Migraine
Therapeutic Areas: Neurology
Year: 2024

Sumatriptan-naproxen is for the acute treatment of migraine. Migraine is a headache that is usually characterised by throbbing in one side of the head and other symptoms including sensitivity to light and sound, nausea and vomiting. The cause of migraines is not known but triggers include tiredness, anxiety and caffeine. Migraines are also thought to be genetic. The two major types are migraine with aura and migraine without aura. Patients experiencing aura can experience numbness, dizziness, and problems with sight. Migraines without aura are the most common and usually last 4-72 hours. Current treatment recommends the combination of triptans (a type of drug which works by narrowing blood vessels around the brain) and nonsteroidal anti-inflammatory drugs (NSAIDs), but there is no single fixed-dose combination therapy currently recommended, leaving an unmet need in the acute treatment of migraine.